Sleepers, Wake Up Because The Real Boom Isn’t Sleep Support, It’s Surviving Tomorrow

Forget Netflix. The hottest bedtime trend of 2025 is knocking yourself out, with precision, purpose, and product.

Welcome to the global sleep-support arms race, where the end goal isn’t dreamy lullabies but cognitive dominance at 7:00am. With the sleep-aids market barrelling toward USD $160+ billion by 2034, the quietest hours of the day are suddenly the loudest battlefield in wellness.

Into this space walks Ārepa, New Zealand’s brain-obsessed beverage brand, now moonlighting as your night-shift neurologist thanks to the launch of its Brain Capsules for Sleep Support. It’s not warm milk. It’s L-theanine, saffron, magnesium and a very calm middle finger to melatonin.

Source: PFN Ai Archives and Arepa Brain Capsules for Sleep Support

Research is showing people aren’t buying sleep to sleep. They’re buying it to survive the next day. Globally, over one in three adults now report sleep issues. Gen Z and Millennials top the charts for insomnia, anxiety, and digital fatigue. But you don’t need data, you need a day without brain fog.

And that’s the shift because sleep isn’t a break. It’s a functional reset.

Ārepa’s answer? A capsule stack nudging your brain into chill mode, lets your nervous system exhale, and actually helps you wake up with enough clarity to remember where you left your phone.

Formulated by neuroscientist Dr Sam Dodd, the two-capsule dose includes 200mg L-theanine (the zen compound found in green tea), 28mg of saffron extract (linked to REM and mood), and 200mg magnesium bisglycinate (bioavailable and calm-inducing without the digestive drama). No fillers. No fake sleepy-bear branding. No next-day fog. Just: sleep, sorted.

But this isn’t just about a fancy sleep supplement. It’s part of a broader shift in New Zealand’s food-as-function playbook. Just last month, Zespri scored EU approval to label its green kiwifruit a functional food, specifically for gut health. One grows fruit, the other grows neurons, but both are exporting something bigger than produce. They’re exporting daily performance.

And the market is wide awake. The global sleep-aid industry is forecast to double from USD $84B to $160B+ within the next decade. Sleep supplements alone are heading toward USD $5B. Meanwhile, nootropic supplements, the brain-boosting siblings of sleep capsules, are on track to triple, hitting $14B by the early 2030s.

Capsules already dominate the format (roughly 50% of nootropic sales), and online D2C is the primary route, especially for brands like Ārepa that already have a loyal, neuro-curious following.

Ārepa’s move into the sleep space signals more than a product launch. It’s a cultural adjustment. The idea that sleep isn’t passive, it’s productive. A supplement not for crashing, but for coping. Sleep not as a luxury, but as leverage for tomorrow. Makes sense to us.

ENDS: